The Latest Cardiac and Vascular News
JLK (www.jlkgroup.com), the leading healthcare AI firm, is poised to make significant inroads into the US market with its groundbreaking healthcare technology with AI for stroke. JLK is the leading company with the world’s largest pool of 11 stroke solutions, including both ischemic and hemorrhagic strokes. In addition, JLK has […]
CAMBRIDGE, Mass., Aug. 14, 2023 /PRNewswire/ — Advanced visualization and AI leader TeraRecon, a ConcertAI company, is proud to announce its strategic partnership with GLEAMER, a leading provider of AI solutions for medical imaging. By joining forces, the two companies aim to advance the field of radiology by integrating GLEAMER’s BoneView and […]
PRINCETON, N.J., Aug. 14, 2023 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that it has completed the pivotal STAR-T (Safe and Timely Antithrombotic Removal – Ticagrelor) randomized, controlled trial, following the last scheduled patient follow-up. The […]
BRISBANE, Australia & MINNEAPOLIS–(BUSINESS WIRE)– Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ THV, a new class of biomimetic heart valve and the world’s only balloon-expandable, single-piece transcatheter aortic valve was implanted in a second successful Valve-in-Valve (ViV) procedure as part of Health Canada’s Special […]
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and other ischemic diseases, today announced a new organizational structure designed to accelerate the company’s growth across its businesses. “From its inception, Imperative Care has taken a unique approach from detection all the way […]
BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for severe, genetic neuromuscular and cardiac disorders for which there is significant unmet medical need, today reported financial results for the second quarter of 2023 and recent business highlights. […]
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced financial results for the second quarter ended June 30, 2023. “Looking ahead, we remain focused on gaining clearance for […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (VECG) platform for patient use at home, allowing for the creation of rich data for AI, has reported its financial and operational results for the second quarter ended […]
BOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today reported recent company progress and financial results for the second quarter of 2023. “We are dedicated to bringing life-changing, once-and-done […]
EDINBURGH, Scotland, Aug. 10, 2023 (GLOBE NEWSWIRE) — Blackford, the pioneering strategic imaging AI platform and solutions provider, and AI4MedImaging, a cardiac MRI solution provider announce a partnership to make the AI4CMR solution available on the Blackford Platform. AI4CMR will enable Blackford customers to automatically segment and quantify cardiac MRI […]
